Risk of progression of monoclonal gammopathy of undetermined significance into lymphoplasmacytic malignancies: determining demographic differences in the USA

Haematologica. 2018 Mar;103(3):e123-e125. doi: 10.3324/haematol.2017.179978. Epub 2017 Dec 21.

Authors

Ronald S Go^{1

2}, Herbert C Heien², Lindsey R Sangaralingham², Elizabeth B Habermann², Nilay D Shah²

Affiliations

¹ Division of Hematology Mayo Clinic, Rochester, MN, USA go.ronald@mayo.edu.
² Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery; Mayo Clinic, Rochester, MN, USA.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Age Factors
Cell Transformation, Neoplastic*
Demography
Disease Progression
Humans
Monoclonal Gammopathy of Undetermined Significance / pathology*
Neoplasms, Plasma Cell / etiology*
Sex Factors
United States